evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract
9493,GENE_SUMMARY,,"PIK3C2G encodes a kinase involved in cell proliferation, oncogenic transformation and protein trafficking signaling pathways. Inactivating mutations of PIK3C2G are found in melanomas and lung and gastrointestinal cancers.",,2017-01-17,,5288,PIK3C2G,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma,False,ENST00000266497,NM_004570.4,PI3K-C2GAMMA,PI3K-C2-gamma,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
9494,GENE_BACKGROUND,,"PIK3C2G is a class II catalytic subunit of PI3-Kinase (PMID: 25785104). PIK3C2G acts as a lipid kinase to create phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P2), which acts as a secondary messenger in key signaling pathways involved in cell cycle, motility, differentiation and transformation (PMID: 10209156). Class II PI3Ks are the least studied, however, they are defined by the presence of a carboxyl-terminal calcium-dependent phospholipid-binding motif (PMID: 22507127). PIK3C2G is mutated in a number of cancers, and a large proportion of these mutations are predicted to be inactivating mutations.",,2017-10-19,,5288,PIK3C2G,phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma,False,ENST00000266497,NM_004570.4,PI3K-C2GAMMA,PI3K-C2-gamma,False,25785104,PIK3C2G copy number is associated with clinical outcomes of colorectal cancer patients treated with oxaliplatin.,International journal of clinical and experimental medicine,2015,8,True,1137-43,Li A et al,,,Li A et al. International journal of clinical and experimental medicine. 2015;8(1)1137-43.,,10209156,Signalling through phosphoinositide 3-kinases: the lipids take centre stage.,Current opinion in cell biology,0001-04-01,11,2,219-25,Leevers SJ et al,,,0001-04-01,,22507127,Regulation and cellular functions of class II phosphoinositide 3-kinases.,The Biochemical journal,2018-05-01T20:12:00,443,3,587-601,Falasca M et al,doi: 10.1042/BJ20120008,,2018-05-01T06:01:00,
